Imperial Collage Healthcare

Digoxin


Test Background
Digoxin is administered for the treatment of heart failure in addition to supraventricular arrhythmias (particularly atrial fibrillation and atrial flutter).


Clinical Indications
Therapeutic drug monitoring Suspected toxicity caution: low potassium (diuretics), thyroid disease, renal impairment or recent myocardial infarction. Contraindicated in hypertrophic cardiomyopathy, intermittent heart-block, ventricular tachycardia


Reference Range

Normal : 0.5-2.0 μg/L Target range in heart failure


Sample Required
SST (gold top)


Sample Collection

Take blood 6 hours post dose


Sample Volume
0.5 mL


Turnaround Time
1 day


Filter by A-Z

Select a test from the left to view more details.